Related Experiment Video
Updated: Jul 23, 2025

Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
Early Experience with the Paul Glaucoma Implant in Childhood Glaucoma: A Case Series
Abdelrahman M Elhusseiny1,2, Mohamed M Khodeiry3,4, Richard K Lee4
1Department of Ophthalmology, Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Insights
The novel Paul glaucoma implant (PGI) effectively lowers intraocular pressure in children with refractory glaucoma. This early study found PGI to be safe and efficient in pediatric cases.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Pediatric Ophthalmology
Background:
- The Paul glaucoma implant (PGI) is a novel, non-valved glaucoma drainage device (GDD) designed to reduce intraocular pressure (IOP) with a theoretically lower risk of complications.
- Limited data exists on PGI use in adult glaucoma, and its application in pediatric glaucoma remains undocumented.
Purpose of the Study:
- To present the initial clinical experience with the Paul glaucoma implant (PGI) in managing refractory childhood glaucoma.
- To evaluate the safety and efficacy of PGI in pediatric glaucoma patients.
Main Methods:
- A retrospective, single-surgeon case series was conducted at a single tertiary center.
- The study included three eyes from three patients diagnosed with childhood glaucoma.
Main Results:
- Over a nine-month follow-up period, all patients demonstrated significantly reduced postoperative IOP and required fewer glaucoma medications compared to preoperative levels.
- No patients experienced postoperative complications, including hypotony, choroidal detachment, endophthalmitis, or corneal decompensation.
Conclusions:
- The Paul glaucoma implant (PGI) appears to be an effective and safe surgical option for refractory childhood glaucoma.
- Further research with larger cohorts and extended follow-up is warranted to validate these preliminary findings.
Purpose:
The Paul glaucoma implant (PGI, Advanced Ophthalmic Innovations, Singapore, Republic of Singapore) is a recently developed novel non-valved glaucoma drainage device (GDD) designed to effectively reduce the intraocular pressure (IOP) in glaucoma patients with a theoretically reduced risk of postoperative complications such as hypotony, endothelial cell loss, strabismus, and diplopia. Limited literature has evaluated its use in adult glaucoma; however, its use in pediatric glaucoma has not been reported to date. We present our early experience with PGI in refractory childhood glaucoma.
Patients And Methods:
This study was retrospective single-surgeon case series in a single tertiary center.
Results:
Three eyes of 3 patients with childhood glaucoma were enrolled in the study. During nine months of follow-up, postoperative IOP and number of glaucoma medications were significantly lower than preoperative values in all the enrolled patients. None of the patients developed postoperative complications including postoperative hypotony, choroidal detachment, endophthalmitis, or corneal decompensation.
Conclusion:
PGI is an efficient and relatively safe surgical treatment option in patients with refractory childhood glaucoma. Further studies with larger number of participants and longer follow-up period are required to confirm our encouraging results.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

